Mersana Therapeutics
MRSN
MRSN
157 hedge funds and large institutions have $437M invested in Mersana Therapeutics in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.11% less ownership
Funds ownership: 4.06% → 3.95% (-0.11%)
26% less capital invested
Capital invested by funds: $590M → $437M (-$153M)
Holders
157
Holding in Top 10
3
Calls
$8.89M
Puts
$662K
Top Buyers
| 1 | +$14.1M | |
| 2 | +$7.75M | |
| 3 | +$6.14M | |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
+$4.87M |
| 5 |
Goldman Sachs
New York
|
+$3.8M |
Top Sellers
| 1 | -$9.87M | |
| 2 | -$3.66M | |
| 3 | -$3.07M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$2.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.7M |